The consultancy warns that the ability to defer tax on employee benefit trusts, one of the key solutions used to...

NICE rejected the use of Avastin, the drug used in treatment against colorectal cancer whose chemical name is bevacizumab, last...

Speaking to Corporate Adviser, Eagle, minister for pensions and the ageingsociety said insurers who provided bad deals for uninformed consumers...

The new business, which is yet to be named, but which will form part of the Paradigm Group of companies...

Harvey, who joins from Axa Corporate Benefits, where he was head of corporate sales for their UK business, will be...

Katharine Moxham, spokesperson for Group Risk Development, which commissioned the research. says the Act, which recently received royal assent, means...

Income Protection Solutions also now offers an exclusions Discount which sees customer’s premiums discounted if they have an exclusion (including...

The firm, which anticipates further growth moving in to 2010, says the difficult economic environment has increased pressure on pension...

Group Risk Development, which commissioned the research, says the fact that the Welfare Reform Act has now received Royal Assent...

Last month Corporate Adviser reported that the FSA had sent a confidential letter to the ABI telling insurers that it...